ESMO26: The “paradigm-shifting” readouts in endometrial & ovarian cancer
At this year’s European Society for Medical Oncology (ESMO) Congress, attention has shifted toward indications that have traditionally received less…
News
ESMO26: Key data breathing new life into the lung cancer field
ESMO26: Combination therapies show promise in prostate cancer
Alnylam reports preliminary Phase Ib trial results for brezosiran
Pfizer reports Phase II data for 25vPnC infant vaccine candidate
ESMO26: Novel combo successes signal shift from frontline chemo in cold cancers
ESMO26: Clinical progress shifts a historically difficult pancreatic cancer landscape
ESMO26: MSD and Moderna drop cancer vaccine trial data early
